UCB extends Bimzelx ad campaign in wake of hidradenitis suppurativa approval

8th July 2025 Uncategorised 0

Several months after the FDA signed off on Bimzelx’s label expansion into hidradenitis suppurativa, UCB is expanding an existing campaign to include the drug’s new indication.

More: UCB extends Bimzelx ad campaign in wake of hidradenitis suppurativa approval
Source: fierce